XLH

Also known as: X-Linked Hypophosphatemia / X-linked Hypophosphatemia (XLH) / X-linked hypophosphataemia / X-Linked Hypohidrotic Ectodermal Dysplasia (XLHED) / XLHED / X Linked Hypohidrotic Ectodermal Dysplasia / X-Linked Hypohidrotic Ectodermal Dysplasia / Rickets, X-Linked Hypophosphatemic / Vitamin D-Resistant Rickets, X-Linked / Familial x-linked hypophosphatemic vitamin D refractory rickets (disorder) / Familial hypophosphatemia / Vit D resistant rickets / Acquired Vitamin D-Resistant Rickets / Rickets (vitamin D resistant) / Rickets - vitamin D resistant / Hereditary hypophosphataemic rickets / Hereditary hypophosphatemic rickets / Vitamin D-dependent rickets, type 2 (disorder) / Rickets familial hypophosphataemic / Familial hypophosphataemic rickets / Familial hypophosphatemic rickets / Rickets familial hypophosphatemic

DrugDrug NameDrug Description
DB14012BurosumabA fibroblast growth factor 23 blocking antibody used to treat X-linked hypophosphatemia.
DrugDrug NameTargetType
DB14012BurosumabFibroblast growth factor 23target
DrugDrug NamePhaseStatusCount
DB00136Calcitriol0Recruiting1
DB14523Phosphate ion0Suspended1
DB14012Burosumab1Completed1
DB18188EDI-2001Completed1
DB14012Burosumab1 / 2Active Not Recruiting1
DB14012Burosumab1 / 2Completed2
DB14012Burosumab2Completed3
DB18188EDI-2002Completed1
DB14012Burosumab3Completed6
DB11094Vitamin D3Completed1
DB14012Burosumab4Active Not Recruiting2
DB14012Burosumab4Completed1
DB14012Burosumab4Unknown Status1
DB00136Calcitriol4Recruiting1
DB14151Phosphorus4Recruiting1
DB14012BurosumabNot AvailableAvailable1
DB14012BurosumabNot AvailableRecruiting1
DB18188EDI-200Not AvailableActive Not Recruiting1